文献速递药物相互作用药物不良反应与药物警戒

改善药物相关临床决策支持系统

Improving medication-related clinical decision support.
PubMed 文献 · Am J Health Syst Pharm · 2018-01-01

本文系统综述了2007至2014年药物相关临床决策支持(CDS)的5个基本功能域的应用现状与改进建议,共纳入156篇全文和28篇会议摘要。核心结论是标准化、整合患者特异性参数以及考虑人因设计原则是实现药物相关CDS潜在获益的关键。

要点

  • 提高警报特异性和敏感性对所有CDS功能域均重要。
  • 分层管理有助于提高药物相互作用(DDI)警报的接受度。
  • 药物剂量警报应个体化并提供实用建议。

核心结论

  • 标准化、整合患者特异性参数以及考虑人因设计原则是实现药物相关CDS潜在获益的核心。
  • 药物相关CDS在某些机构仍相对不成熟,有较大改进空间。

研究设计与样本

  • 系统综述,通过MEDLINE和EMBASE检索2007至2014年发表的文献,使用MeSH词和关键词涉及5个基本药物相关CDS功能域。
  • 共审阅156篇全文和28篇会议摘要,覆盖DDI检查(n=78)、药物过敏检查(n=20)、药物剂量支持(n=55)、药物重复检查(n=11)和药物目录支持(n=20)。

主要发现

  • 药物相关CDS的成功取决于用户认为警报有价值并依据所获信息采取行动。
  • 提高警报特异性和敏感性对所有功能域均重要。
  • 分层管理对提高DDI警报接受度重要。
  • 执行适当交叉敏感性检查的能力是产生适当药物过敏检查的关键。
  • 药物剂量警报应个体化并提供实用建议;系统配置识别某些药物重复的方式对防止潜在患者毒性重要;需要准确的知识库来产生相关药物目录警报并鼓励目录依从性。

关键数值与推荐

  • 决策支持应考虑更多患者特异性因素。
  • 应始终考虑人因原则。
  • 必须提高警报特异性以减少警报疲劳。

临床怎么用

  • 在设计和优化药物相关CDS时,应优先提高警报特异性与敏感性,并对DDI警报实施分层管理。
  • 药物剂量警报应个体化并给出可操作建议,药物过敏检查应能执行适当的交叉敏感性检查。
  • 应整合患者特异性参数并遵循人因设计原则,以减少警报疲劳并提升CDS接受度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Current uses of medication-related clinical decision support (CDS) and recommendations for improving these systems are reviewed. SUMMARY: Using a systematic approach, articles published from 2007 through 2014 were identified in MEDLINE and EMBASE using MeSH terms and keywords relating to the 5 basic medication-related CDS functionalities. A total of 156 full-text articles and 28 conference abstracts were reviewed across each of the 5 areas: drug-drug interaction (DDI) checks (n = 78), drug allergy checks (n = 20), drug dose support (n = 55), drug duplication checks (n = 11), and drug formulary support (n = 20). The success of medication-related CDS depends on users finding the alerts valuable and acting on the information received. Improving alert specificity and sensitivity is important for all domains. Tiering is important for improving the acceptance of DDI alerts. The ability to perform appropriate cross-sensitivity checks is key to producing appropriate drug allergy checks. Drug dosage alerts should be individualized and deliver practical recommendations. How the system is configured to identify certain drug duplications is important to prevent possible patient toxicity. Accurate knowledge databases are needed to produce relevant drug formulary alerts and encourage formulary adherence. Medication-related CDS is still relatively immature in some organizations and has substantial room for improvement. For example, decision support should consider more patient-specific factors, human factors principles should always be considered, and alert specificity must be improved in order to reduce alert fatigue. CONCLUSION: Standardization, integration of patient-specific parameters, and consideration of human factors design principles are central to realizing the potential benefits of medication-related CDS.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Tolley CL, Slight SP, Husband AK, et al. Improving medication-related clinical decision support. Am J Health Syst Pharm. 2018. PMID: 29436470. doi:10.2146/ajhp160830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。